1. State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
- Author
-
Victor M. Cardenas, Joshua L. Kennedy, Mark Williams, Wendy N. Nembhard, Namvar Zohoori, Ruofei Du, Jing Jin, Danielle Boothe, Lori A. Fischbach, Catherine Kirkpatrick, Zeel Modi, Katherine Caid, Shana Owens, J. Craig Forrest, Laura James, Karl W. Boehme, Ericka Olgaard, Stephanie F. Gardner, and Benjamin C. Amick
- Subjects
Adult ,Cross-Sectional Studies ,Multidisciplinary ,SARS-CoV-2 ,Seroepidemiologic Studies ,COVID-19 ,Humans ,Hispanic or Latino - Abstract
The purpose of this cross-sectional study was to estimate the proportion of Arkansas residents who were infected with the SARS-CoV-2 virus between May and December 2020 and to assess the determinants of infection. To estimate seroprevalence, a state-wide population-based random-digit dial sample of non-institutionalized adults in Arkansas was surveyed. Exposures were age, sex, race/ethnicity, education, occupation, contact with infected persons, comorbidities, height, and weight. The outcome was past COVID-19 infection measured by serum antibody test. We found a prevalence of 15.1% (95% CI: 11.1%, 20.2%) by December 2020. Seropositivity was significantly elevated among participants who were non-Hispanic Black, Hispanic (prevalence ratio [PRs]:1.4 [95% CI: 0.8, 2.4] and 2.3 [95% CI: 1.3, 4.0], respectively), worked in high-demand essential services (PR: 2.5 [95% CI: 1.5, 4.1]), did not have a college degree (PR: 1.6 [95% CI: 1.0, 2.4]), had an infected household or extra-household contact (PRs: 4.7 [95% CI: 2.1, 10.1] and 2.6 [95% CI: 1.2, 5.7], respectively), and were contacted in November or December (PR: 3.6 [95% CI: 1.9, 6.9]). Our results indicate that by December 2020, one out six persons in Arkansas had a past SARS-CoV-2 infection.
- Published
- 2022
- Full Text
- View/download PDF